Abstracts

852 – Efficacy and Safety of B/F/TAF in Children and Infants Aged ≥1 Month, Weighing 3 to <25 kg: Week 24

Background Treatment options for children with HIV are limited. Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a well-tolerated antiretroviral therapy (ART) with a high barrier to resistance approved in the US for children weighing ≥14 kg and in other countries for children ≥25 kg. However, data on its use in younger children are limited. We present efficacy and safety outcomes for…

341 – Parallelized Genome-Wide Detection of Intact HIV Provirus With Bimodal Phenotyping in Single Cells

Background Prolonged cART is associated with a greater proportion of provirus in closed chromatin and shifted reservoir landscape. However, current single cell reservoir approaches are unable to detect a heterochromatic provirus while maintaining the ability to simultaneously define the features of its host CD4+ T cell. To enable rational targeting of the reservoir, we hypothesized…

891 – Longitudinal Dynamics of SARS-CoV-2 Antireceptor Binding Domain Antibodies in Healthcare Workers

Background Prior SARS-CoV-2 infection and vaccination impact the magnitude and durability of anti-receptor binding domain (RBD) IgG. We aimed to characterise longitudinal anti-RBD dynamics in HCWs with and without prior infection in the SORTED (Seroprevalence, Seroconversion Rates and Transmission Dynamics of SARS-CoV-2 among Healthcare Workers) study. Methods Recruitment occurred from July 2020 to September 2021…

1121 – Progress and Gaps in Cervical Cancer Screening and Treatment Among African Women Living With HIV

Background Women living with HIV (WLWH) in sub-Saharan Africa (SSA) are disproportionately affected by cervical cancer, yet population data on screening and treatment in high-burden settings remain scarce. In light of the revised World Health Organization guidelines on cervical cancer diagnostics and care for WLWH, there is a need to assess progress and gaps along…

1045 – DoxyPEP Counseling and Use Among PrEP Users: Cross-Sectional Survey in the Italian PrIDE Cohort

Background Doxycycline postexposure prophylaxis (DoxyPEP) patterns of counseling and uptake among European PrEP users are scarce. In Italy, no official DoxyPEP guidelines are available. Aims are to assess the prevalence of DoxyPEP counseling and use in Italy and to identify associated factors to guide equitable scale-up. Methods This is a cross-sectional analysis of PrEP users…

328 – Accelerated Longitudinal Decline of Intact Proviruses During ART in the LoViRet Cohort

Background Among people living with HIV (PLWH) receiving long-term antiretroviral therapy (LT-ART), the frequency of intact HIV-1 proviruses varies considerably, likely reflecting differences in immune pressure on the reservoir cell pool. Characterizing reservoir dynamics in individuals with exceptionally low reservoir under ART may provide critical insights for reservoir reduction and HIV cure strategies. In this…

347 – High-Throughput HIV-1 Reservoir Mapping: Intactness, Drug Resistance, and Immune Therapy Predictions

Background HIV-PULSE (HIV Proviral Unique molecular identifier mediated Long-read Sequencing) is a novel and cost-effective assay for near full-length (NFL) HIV-1 proviral sequencing. A detailed understanding of the viral reservoir is crucial for advancing curative efforts. This study explores the potential of HIV-PULSE to profile the HIV-1 reservoir in a high-throughput manner by analyzing key…